Premier Alternatives

Deepcell

Menlo Park, CA · Founded 2015 · Privately Held (backing)

Developer of microfluidic imaging platform designed to offer non-invasive genetic tests with diagnostic-level accuracy. Deepcell is based in Menlo Park, CA and was founded in 2015. It was valued at $223 million at its later-stage round in Mar 2022, the last priced event on record. It has raised $98 million across 3 recorded rounds; the latest was a $73 million later-stage round in Jan 2022.

PMV mark · valuation
$223.0M
Oct 2026
Priced at
its later-stage round
Mar 2022
Total raised
$98.0M
Last round
Later Stage VC
Jan 2022

Deepcell key facts

as of Oct 2026
  • Developer of microfluidic imaging platform designed to offer non-invasive genetic tests with diagnostic-level accuracy.
  • Deepcell is valued at approximately $223.0M as of Oct 2026, set at its later-stage round, Mar 2022; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $98.0M across 3 recorded rounds; the latest was Later Stage VC ($73.0M) in Jan 2022.
  • Notable investors include Andreessen Horowitz, DCVC, Jeff Dean, Fifty Years, Horizons Ventures — 11 tracked in total.
  • Deepcell has filed 3 Form Ds with the SEC since 2017, most recently Oct 2022 ($73.0M sold to 16 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$223.0M

Valued at $223.0M at its later-stage round, Mar 2022. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Deepcell with a free account
  • ·The complete investor list: 11 names
  • ·Watch Deepcell: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Deepcell funding rounds

3 rounds
Jan 2022Later Stage VC$73.0MSEC filing▮
Sep 2019Early Stage VC$20.0MSEC filing▮
Dec 2017Seed Round$4.0MSEC filing▮
Full funding history →

Deepcell valuation

Deepcell was valued at $223 million at its later-stage round in Mar 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Deepcell raised?

Deepcell has raised $98 million across 3 recorded rounds since 2017. The largest was a $73 million later-stage round in Jan 2022.

Deepcell has filed 3 Form Ds with the SEC since 2017, most recently in Oct 2022 ($73 million sold to 16 investors).

Deepcell investors

11 investors are on record for Deepcell, including Andreessen Horowitz, DCVC, Jeff Dean and Fifty Years. By type, the record holds 7 venture capital firms. The later-stage round in Jan 2022 drew 16 investors.

About Deepcell

Developer of microfluidic imaging platform designed to offer non-invasive genetic tests with diagnostic-level accuracy. The company's platform utilizes artificial intelligence to classify cells based on detailed visual features and isolates viable cells based on morphological distinctions, enabling researchers to eliminate the need for invasive diagnostic tests.

Sector
Healthcare
HQ
Menlo Park, CA, United States
Founded
2015
Employees
100
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.